American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients.

ABSTRACT:

Background

COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE).

Objective

These evidence-based guidelines from the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in making decisions about the use of anticoagulation in patients with COVID-19.

Methods

ASH formed a multidisciplinary guideline panel that included patient representatives and applied strategies to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process and performed systematic evidence reviews (through November 2021). The panel prioritized clinical questions and outcomes according to their importance for clinician

SUBMITTER: Cuker A 

PROVIDER: S-EPMC9068240 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature